Expression of Concern: C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo

The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper “C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo” DOI: 10.1042/BSR20201541, hence has issued an expression of concern to notify readers. It has been noted that Figure 4C A549 si-C1QTNF6 panel in this paper seems to appear as Figure 7E A549/sh-SNHG3 Invasion NC inhibitors panel in a paper with overlapping submission dates: Zhao et al, 2021 (DOI: 10.3892/ijmm.2021.4980) [retracted]. Additionally, Figure 1F A549 Blank Control, A549 si-NC, and SPCA-1 pc-C1QTNF6 panels seem to appear as Figure 2A Solvent control, LPS+ATP, and LPS+ATP+50µM Lovastatin panels in a subsequent publication from Liu et al, 2022 (DOI: 10.21037/tcr-22-346) [retracted].The authors have been contacted regarding these concerns and have corresponded with the journal. The authors state the results are their own work and provided the original data pertaining to their article, for which no further issues have been identified. However the authors' response did not fully resolve the concerns regarding the overlapping data with the other articles.

Publication Details

Journal
Bioscience Reports
Published
2024-10-01
DOI
https://doi.org/10.1042/bsr-2020-1541_eoc
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expression of Concern: C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo

Bioscience Reports
PARP inhibition in cancer therapy
article

Expression of Concern: C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo

article en

Abstract

The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper “C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo” DOI: 10.1042/BSR20201541, hence has issued an expression of concern to notify readers. It has been noted that Figure 4C A549 si-C1QTNF6 panel in this paper seems to appear as Figure 7E A549/sh-SNHG3 Invasion NC inhibitors panel in a paper with overlapping submission dates: Zhao et al, 2021 (DOI: 10.3892/ijmm.2021.4980) [retracted]. Additionally, Figure 1F A549 Blank Control, A549 si-NC, and SPCA-1 pc-C1QTNF6 panels seem to appear as Figure 2A Solvent control, LPS+ATP, and LPS+ATP+50µM Lovastatin panels in a subsequent publication from Liu et al, 2022 (DOI: 10.21037/tcr-22-346) [retracted].The authors have been contacted regarding these concerns and have corresponded with the journal. The authors state the results are their own work and provided the original data pertaining to their article, for which no further issues have been identified. However the authors' response did not fully resolve the concerns regarding the overlapping data with the other articles.

Bioscience ReportsVol. 44(10)
Zero hunger
Openalex Percentile: Top 66%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Expression of Concern: C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo · Bioscience Reports (2024) | TGRS Research Map | TGRS